Home | List of Topics | Lungs | Interstitial Lung Disease (ILD)
Acute silicosis is lung inflammation due to breathing in large amounts of silica dust or silicon dioxide over several months.
The disease occurs mainly in people who work in sandblasting, mining, quarrying, grinding, and those who work in foundries. Silicosis is becoming less common due to U.S. Occupational Safety and Health Administration (OSHA) regulations that require protective equipment.
The mucous membranes may have a bluish color (cyanosis). Often, the doctor can hear abnormal lung sounds with a stethoscope.
Tests that may be done include:
There is no specific treatment for silicosis. Whole-lung lavage or treatment with corticosteroids may be attempted. For those with end-stage lung disease, lung transplantation may be an option.
Supportive treatment includes cough suppression medications, bronchodilators, and oxygen if needed for shortness of breath. Antibiotics are prescribed for respiratory infections as needed. In general, silicosis patients should be screened for tuberculosis and treated if indicated.
The outcome depends on the severity of lung scarring. The severity of the disease is usually related to the amount of silica to which the person was exposed. Acute silicosis has a poor prognosis.
A complication is respiratory failure. Patients with silicosis are at increased risk of developing pulmonary tuberculosis.
Call for an appointment with your health care provider if you have occupational exposure to silica and you develop symptoms.
If you work in a high-risk occupation, wear a dust mask and do not smoke. You also may need other protection, such as a respirator.
Ferri FF. Ferri's Clinical Advisor 2007: Instant Diagnosis and Treatment. 9th ed. Philadelphia, Pa: Mosby; 2006.
Glazer CS, Newman LS. Occupational interstitial lung disease. Clin Chest Med. September 2004;25:467-478.
Pipavath S, Godwin JD. Imaging of interstitial lung disease. Clin Chest Med. September 2004;25:455-465.
Review Date:3/1/2007
Reviewed By:David A. Kaufman, MD Assistant Professor, Division of Pulmonary Medicine, Mount Sinai School of Medicine, New York, NY. Review provided by VeriMed Healthcare Network.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.
Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.